C6H4Br2FN, monoclinic, P21/c (no. 14), a = 17.0332(5) Å, b = 4.34070(10) Å, c = 21.9732(5) Å, β = 109.6910(10)°, V = 1529.61(7) Å3, Z = 8, Rgt(F) = 0.0256, wRref(F2) = 0.0518, T = 200 K
C34H32Br4N4O4, Mr = 880.27, monoclinic, P21/n (no. 14), a = 16.3126(5) Å, b = 6.9654(2) Å, c = 29.30...
In the title compound, C15H10Br2F2O, the dihedral angle between the two 3-fluoro-substituted benzene...
R factor = 0.030; wR factor = 0.079; data-to-parameter ratio = 17.2. In the title compound, C20H12Br...
C20H18F2N2, monoclinic, P21/c (no. 14), a = 12.4233(11) Å, b = 7.3805(7) Å, c = 18.9531(16) Å, β = 1...
C16H11BF2N2, monoclinic, P21/c (no. 14), a = 9.0978(14) Å, b = 18.580(3) Å, c = 15.476(2) Å, β = 99....
The crystal structure of the title compound C13H8Cl2FN has been determined at room temperature. Colo...
C9H8BrF2NO2S, triclinic, P1̅ (no. 2), a = 7.5277(6) Å, b = 8.3730(7) Å, c = 9.8785(9) Å, α = 92.637(...
C28H18Br4CuF2N2O2, monoclinic, C2 (no. 5), a = 14.6518(8) Å, b = 9.6738(5) Å, c = 11.1907(6) Å, ...
C30H14Br2F4I2N4, monoclinic, P21/c (no. 14), a = 9.4531(3) Å, b = 40.9487(15) Å, c = 7.5118(3) Å, β ...
C16H11Cl2FN2, orthorhombic, Pbca (no. 61), a = 9.6732(3) Å, b = 15.5602(5) Å, c = 19.0881(6) Å, V = ...
C6H4BrI, monoclinic, P21/c (no. 14), a = 4.1704(6) Å, b = 5.8242(8) Å, c = 14.929(2) Å, β = 97.315(5...
In the title compound, C14H8Br2FN3O2, the nitro-substituted benzene ring and the 4-fluorophenyl ring...
In the title compound, C14H8Br2FN3O2, the 4-fluorophenyl ring and the nitro-substituted phenyl ring ...
C18H20BrFN2O1, monoclinic, P21/c (no. 14), a = 14.1884(10) Å, b = 5.3673(4) Å, c = 22.3768(15) Å, β ...
C26H14Br2F4I2N4, triclinic, P1̄ (no. 2), a = 8.7472(4) Å, b = 8.7822(4) Å, c = 9.4065(4) Å, α = 102....
C34H32Br4N4O4, Mr = 880.27, monoclinic, P21/n (no. 14), a = 16.3126(5) Å, b = 6.9654(2) Å, c = 29.30...
In the title compound, C15H10Br2F2O, the dihedral angle between the two 3-fluoro-substituted benzene...
R factor = 0.030; wR factor = 0.079; data-to-parameter ratio = 17.2. In the title compound, C20H12Br...
C20H18F2N2, monoclinic, P21/c (no. 14), a = 12.4233(11) Å, b = 7.3805(7) Å, c = 18.9531(16) Å, β = 1...
C16H11BF2N2, monoclinic, P21/c (no. 14), a = 9.0978(14) Å, b = 18.580(3) Å, c = 15.476(2) Å, β = 99....
The crystal structure of the title compound C13H8Cl2FN has been determined at room temperature. Colo...
C9H8BrF2NO2S, triclinic, P1̅ (no. 2), a = 7.5277(6) Å, b = 8.3730(7) Å, c = 9.8785(9) Å, α = 92.637(...
C28H18Br4CuF2N2O2, monoclinic, C2 (no. 5), a = 14.6518(8) Å, b = 9.6738(5) Å, c = 11.1907(6) Å, ...
C30H14Br2F4I2N4, monoclinic, P21/c (no. 14), a = 9.4531(3) Å, b = 40.9487(15) Å, c = 7.5118(3) Å, β ...
C16H11Cl2FN2, orthorhombic, Pbca (no. 61), a = 9.6732(3) Å, b = 15.5602(5) Å, c = 19.0881(6) Å, V = ...
C6H4BrI, monoclinic, P21/c (no. 14), a = 4.1704(6) Å, b = 5.8242(8) Å, c = 14.929(2) Å, β = 97.315(5...
In the title compound, C14H8Br2FN3O2, the nitro-substituted benzene ring and the 4-fluorophenyl ring...
In the title compound, C14H8Br2FN3O2, the 4-fluorophenyl ring and the nitro-substituted phenyl ring ...
C18H20BrFN2O1, monoclinic, P21/c (no. 14), a = 14.1884(10) Å, b = 5.3673(4) Å, c = 22.3768(15) Å, β ...
C26H14Br2F4I2N4, triclinic, P1̄ (no. 2), a = 8.7472(4) Å, b = 8.7822(4) Å, c = 9.4065(4) Å, α = 102....
C34H32Br4N4O4, Mr = 880.27, monoclinic, P21/n (no. 14), a = 16.3126(5) Å, b = 6.9654(2) Å, c = 29.30...
In the title compound, C15H10Br2F2O, the dihedral angle between the two 3-fluoro-substituted benzene...
R factor = 0.030; wR factor = 0.079; data-to-parameter ratio = 17.2. In the title compound, C20H12Br...
DOI
Add to ORKG